VC-backed Candel goes public
Candel Therapeutics, a clinical stage biopharmaceutical company, has raised $72 million for its IPO after pricing its 9 million shares at $8 per share.
Candel Therapeutics, a clinical stage biopharmaceutical company, has raised $72 million for its IPO after pricing its 9 million shares at $8 per share.
Copyright PEI Media
Not for publication, email or dissemination